Tandem Diabetes Care Inc Capital Reinvestment Ratio
Tandem Diabetes Care Inc capital reinvestment ratio. Tandem Diabetes Care Inc (TNDM) has a Capital Reinvestment Ratio of 0.57x as of March 2026, meaning it reinvests 1% of its operating cash flow ($11.05 Million) in capital expenditures ($6.27 Million). Check TNDM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tandem Diabetes Care Inc (2019–2024)
Capital reinvestment ratio of Tandem Diabetes Care Inc from 2019 to 2024. This chart tracks Tandem Diabetes Care Inc's Capital Reinvestment Ratio across 5 annual periods. Also explore Tandem Diabetes Care Inc net asset momentum to track the company's year-over-year net asset growth rate.
Tandem Diabetes Care Inc Capital Reinvestment Ratio by Year (2019–2024)
Tandem Diabetes Care Inc capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see Tandem Diabetes Care Inc operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | $24.23 Million | $19.23 Million | ▲ +17.5% |
| 2022 | 0.68x | $50.46 Million | $34.10 Million | ▲ +220.0% |
| 2021 | 0.21x | $111.36 Million | $23.51 Million | ▼ -83.9% |
| 2020 | 1.31x | $24.67 Million | $32.29 Million | ▲ +180.7% |
| 2019 | 0.47x | $41.91 Million | $19.54 Million | — |